ENT Updates

Clinical Research

Oncologic outcomes of surgical treatment in supraglottic larynx cancer

Downloads

Akın, İstemihan, Vuralkan, E., Günsoy, B., Saka, C., Akçayöz, N., & Şimşek, G. (2013). Oncologic outcomes of surgical treatment in supraglottic larynx cancer. ENT Updates, 3(1). https://doi.org/10.2399/jmu.2013001003

Authors

  • İstemihan Akın T.C. Sağlık Bakanlığı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Kulak Burun Boğaz Hastalıkları Kliniği, Ankara
  • Erkan Vuralkan
    T.C. Sağlık Bakanlığı Kanuni Eğitim ve Araştırma Hastanesi, Kulak Burun Boğaz Hastalıkları Kliniği, Trabzon
  • Behçet Günsoy T.C. Sağlık Bakanlığı Gaziantep Devlet Hastanesi, Kulak Burun Boğaz Hastalıkları Bölümü, Gaziantep
  • Cem Saka T.C. Sağlık Bakanlığı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Kulak Burun Boğaz Hastalıkları Kliniği, Ankara
  • Nihat Akçayöz T.C. Sağlık Bakanlığı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Kulak Burun Boğaz Hastalıkları Kliniği, Ankara
  • Gökçe Şimşek T.C. Sağlık Bakanlığı Yeşilyurt Hasan Çalık Devlet Hastanesi, Malatya

Objective: To evaluate the oncologic results from our experience in performing laryngectomy for patients with supraglottic laryngeal cancer.

Methods: Seventy five consecutive patients who underwent laryngectomy for laryngeal cancer in our department from January 1998 to December 2006 have been reviewed. Seventy two males and 3 females were involved. Their ages ranged from 35 to 70 (average 53.64±8.27) years. Reports of the site and stage of tumor, preoperative or postoperative radiotherapy, complications and the histopathologic examination were reviewed.

Results: All tumors were squamous cell carcinoma originating at the supraglottis. Most cancers (73.4%) were classified as stage III/IV. Surgical techniques were including supraglottic partial laryngectomy (n=15, 20%), supracricoid partial laryngectomy (n=3, 4%), total laryngectomy (n=57, 76%). Bilateral (73, 97.3%) and unilateral (2, 2.7%) neck dissections were performed. Fourty patients were treated by radiotherapy after surgery. Regional recurrence occurred in 5 cases. Local recurrence occurred in 2 patients. Median follow-up time was 46.25±23.90 months. The overall survivals were 86.6% for all stages.

Conclusion: Stage of tumor and neck should be evaluated carefully before the treatment of laryngeal cancer. Treatment should be specific for patient and ideas of patient must be taken into consideration.

Keywords:

Supraglottic cancer laryngectomy recurrence survey